Abstract
Dozee was established in 2015 by Mudit Dandwate and Gaurav Parchani, when they were both 31 years old. Dandwate and Parchani quit high-paying, high-tech jobs to begin working on ideas for a health tech start-up in India. Building on the concept of ballistocardiography and using software that incorporated Artificial Intelligence and Machine Learning (AI/ML), the founders aimed to create a prototype that could measure vital parameters of the human body such as heart rate and respiratory rate and other clinical parameters such as sleep apnoea and cardiac performance metrics. When developing the prototype, they serendipitously discovered a contactless way of monitoring human body sensations. After a year of experimentation, Dandwate and Parchani created a device called “Dozee.” The device, in the form of a mat that could be placed under the mattress of a user, would continuously monitor the user’s vital parameters to detect unusual signs and symptoms. Dozee was developed to serve two types of users: 1) home users or those with chronic conditions that needed monitoring, and 2) hospital users who could be continuously monitored by medical personnel. The user’s data could be accessed by their doctor and by family members or caregivers through an application (app) interface. The Dozee system sent an “Alert” notification to the user and the tracker if any anomalies were detected in the vital parameters. In March 2020, when the COVID-19 pandemic first affected India, the demand for contactless monitoring skyrocketed. Therefore, the adoption of Dozee increased in various hospitals, both public and private, across India. In addition to scaling up, the company continued to implement various technology improvements. With the arrival of vaccines a year later, and the lifting of pandemic-induced lockdowns, the threat of the pandemic diminished, leading to a reduction in demand for the contactless monitoring device from Dozee. In 2021, the founders of Dozee confronted a challenge—how could they scale up and meet their short-term target of servicing 50,000 beds by 2024 and their long-term target of serving 2 million users?
Additional Information
| Product Type | Case |
|---|---|
| Reference No. | CIIE0030 |
| Title | Dozee: Scaling a Digital Healthcare Product Start-up in India |
| Pages | 19 |
| Published on | Feb 26, 2025 |
| Year of Event | 2021 |
| Authors | Mendonca, Valerie; Laha, Arnab; |
| Area | Centre for Innovation, Incubation, and Entrepreneurship (CIIE) |
| Discipline | Innovation and Entrepreneurship |
| Sector | Health |
| Learning Objective | ● To understand how a health tech start-up could be scaled up: The case could be used to understand the issues and challenges faced when scaling up a health tech start-up in India. ● To understand the technology adoption life-cycle of a start-up: The case helps participants understand the technology adoption life-cycle, specifically in the context of a start-up. Although the case does not directly describe the tech journey of a startup, it could be used to discuss the future of technology and its implications for a startup, especially in the face of rapidly changing technology. Thus, participants would be able to anticipate the challenges of a start-up that is highly reliant on technology. ● To understand the risks of entrepreneurship: The case could be used to discuss the risks of entrepreneurship. The highlighting of key business decisions through the lens of prospect theory will equip aspiring entrepreneurs to navigate the risks involved in establishing and running a start-up. |
| Keywords | Entrepreneurship; Start-up; Health-tech; Healthcare |
| Country | India |
| State | Karnataka |
| City | Bengaluru |
| Organization | Turtle Shell Technologies Pvt. Ltd. |
| Access | For All |
My Cart
You have no items
in your shopping cart.